This announcement is a separate document:
ゼリア新薬工業：アコチアミド塩酸塩水和物の欧州・米国・カナダ地域における 機能性ディスペプシア治療剤としての開発および販売契約締結のお知らせ
Zeria Pharmaceutical: Announcements of individual stocks: Development and sales contract for functional dyspepsia treatment using acotiamide hydrochloride hydrate in European, USA, and Canada regions.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.